Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Atossa Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 54 | 90 | +36 |
| Shares | 10.8M | 35.7M | +24.9M (+230.1%) |
| Value | $22.8M | $225.8M | +$203.0M (+888.3%) |
New holders (57)
Institutions that held Atossa Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (21)
Institutions that held Atossa Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Renaissance Technologies LLC | 3,304,140 | $6.97M |
| CVI Holdings, LLC | 432,305 | $912.0K |
| Capstone Investment Advisors, LLC | 51,257 | $108.0K |
| Creative Planning | 48,666 | $103.0K |
| Citadel Advisors LLC | 34,070 | $72.0K |
| Meitav Dash Investments Ltd | 30,000 | $63.0K |
| Bienville Capital Management, LLC | 28,379 | $60.0K |
| UBS Group AG | 26,170 | $55.0K |
| Gsa Capital Partners LLP | 22,925 | $48.0K |
| XTX Topco Ltd | 20,392 | $43.0K |
| LMR Partners LLP | 19,317 | $41.0K |
| Royal Fund Management, LLC | 15,000 | $31.0K |
| Kestra Advisory Services, LLC | 13,700 | $29.0K |
| Independent Advisor Alliance | 10,000 | $21.0K |
| Newbridge Financial Services Group, Inc. | 7,000 | $15.0K |
| Retirement Group, LLC | 1,250 | $3.00K |
| Bank of Montreal | 1,000 | $2.00K |
| AdvisorNet Financial, Inc | 1,000 | $2.00K |
| Sowell Financial Services LLC | 800 | $2.00K |
| Signaturefd, LLC | 600 | $1.00K |
| Eudaimonia Partners, LLC | 54 | $0 |